Abiopharma

🔍 COSSET YAEL (Director)

Company: KOHLS Corp (KSS)

Report Date: 2026-06-24

Detailed Transactions and Holdings:

• Acquired 89 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 70,667.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 51 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 70,718.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: Award of additional restricted stock in lieu of $0.125 per share dividend issued by the Company on all common stock, which was payable on June 24, 2026. These shares vest on the same schedule as the underlying shares of restricted stock.
• F2: Award of additional deferred restricted stock units in lieu of $0.125 per share dividend issued by the Company on all common stock, which was payable on June 24, 2026. These units will be settled on the same schedule as the underlying deferred restricted stock units.
• F3: Includes 13,603 unvested shares of restricted stock.